Come up with a name for your new list and we'll add to it:
Trigen Laboratories raised a round of funding on December 16, 2013. Investors include
Avista Capital Partners.
Trigen Laboratories is a generic pharmaceutical company offering unique products across an increasing array of categories. Trigen seeks to bring value-driven generic products to its customers, workin…